Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Alicia Morgans, MD, MPH

Medical Oncology

Make an Appointment
Watch Video

Alicia Morgans, MD, MPH


  • Medical Director, Survivorship Program
  • Physician
  • Member of the Faculty of Medicine, Harvard Medical School

Clinical Interests

  • Cancer survivorship
  • Quality of life
  • Shared decision making

Contact Information

  • Appointments877-332-4294 (new patients)
    617-582-9725 (established patients)
  • Office Phone Number857-215-1605
  • Fax617-632-2165


Alicia Morgans is a Genitourinary Medical Oncologist and the Medical Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported outcome measures, as well as incorporating patient preferences and beliefs into clinical decision making. Her research has investigated complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic, and cognitive complications. Her work has been funded by grants from the Prostate Cancer Foundation and the Department of Defense. She is a member of the advanced and localized prostate cancer treatment guidelines committee of the American Urologic Association, and is a member of the cardio-oncology committee of the American Heart Association. Since 2016, she has been President of the Medical Advisory Board for ZERO, a non-profit organization dedicated to supporting education and research funding for prostate cancer research.

Board Certification:

  • Medical Oncology, 2012


  • Dana-Farber Cancer Institute / Massachusetts General Hospital


  • Hospital of the University of Pennsylvania

Medical School:

  • University of Pennsylvania, Perelman School of Medicine


Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions